<DOC>
	<DOCNO>NCT00996463</DOCNO>
	<brief_summary>The rationale clinical trial compare intralesional antimonial therapy versus wind care management patient old world cutaneous leishmaniasis ( OWCL ) follow : 1 . The effectiveness current mainstay treatment intralesional antimonials CL subject discussion , especially L. major lesion predominant Northern Afghanistan 2 . The importance wind care management patient OWCL emphasize Gonzalez et al . ( 2008 ) efficacy confirm Kabul trial L. tropica patient . Parallel clinical efficacy trial investigate cost-effectiveness -utility treatment option study .</brief_summary>
	<brief_title>Rationales Wound Care Management Old World Cutaneous Leishmaniasis Patients</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Leishmaniasis</mesh_term>
	<mesh_term>Leishmaniasis , Cutaneous</mesh_term>
	<mesh_term>Antimony Sodium Gluconate</mesh_term>
	<criteria>1 . Present suspect Old World Cutaneous Leishmaniasis lesion confirm Giemsa stain wound smear skin disease infection 2 . Have never previously treat antimonial injection form antileishmanial medication . 1 . Patients one lesion exclude . 2 . Patients lesion age &gt; 3 month also exclude . The experience Kabul trial show patient present first time lesion , old three month , either pretreated somewhere else and/or show poor compliance trial . 3 . Patients 12 year age exclude trial , fill EQ5D Skindex questionnaire part health economic evaluation . 4 . Intralesional antimony injection painful lesion locate nose , lip eye . Therefore , patient present lesion exclude trial . 5 . For compliance reason addict patient patient available followup exclude trial . 6 . Patients major uncontrolled disease tuberculosis , diabetes HIV exclude trial , since management require additional comedications , may affect wound healing .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>